Reuters Health Report

Click to View in Browser 10/1/2014 U.S. health experts in Dallas reviewing potential Ebola exposure WASHINGTON (Reuters) - U.S. health experts in Dallas on Wednesday were examining how many people may have been exposed to Ebola, just one day after the first case of the deadly virus was diagnosed in the United States, the nation's top public health official said. Exclusive: India set to run out of critical free drug for HIV/AIDS program NEW DELHI (Reuters) - India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Novo Nordisk's next big idea: a once-weekly insulin shot COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's largest insulin maker, is betting on a new way to stay ahead in the $40 billion-plus diabetes market by trying to develop the world's first once-weekly insulin injection. Portola Pharma drug reverses effect of anti-clotting drugs in study (Reuters) - Portola Pharmaceuticals Inc said its drug met the main goal of reversing the effect of anti-coagulant drugs in a late-stage study. Ardelyx bowel drug succeeds in mid-stage trial (Reuters) - Ardelyx Inc said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of increasing bowel movement compared with a placebo in a mid-stage study involving 371 patients. Walgreen to sell drugs under Express Scripts 2015 Medicare plans (Reuters) - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said Walgreen Co would sell prescription drugs under its two Medicare Part D plans for 2015. West Africa Ebola crisis hits tourism, compounds hunger in Gambia DAKAR (Thomson Reuters Foundation) - Pestilence, cyclical droughts and floods, and the West Africa Ebola crisis have pushed hunger to record levels in Gambia, where 200,000 people need urgent food assistance, the United Nations says. Plant-based vaccines challenge big pharma for $3 billion flu market NEW YORK (Reuters) - Two tiny companies are preparing to challenge some of the world's largest drug makers in the battle for dominance in the $3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants. Mexico says Ghanaian patient shows no signs of Ebola virus MEXICO CITY (Reuters) - A 52-year-old man from Ghana who has been hospitalized in Mexico does not shows signs of the deadly Ebola virus, the country's health ministry said in a statement on Tuesday night. Spouse personality may affect career success NEW YORK (Reuters Health) - The personalities of husbands and wives may affect their spouses' success at work, suggests a new study. Related Video Gelatine "bump" label could change food packaging industry New copper-based fabric promises germ-free hospital environment The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend